Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.65 USD | +7.68% |
|
+34.30% | +343.75% |
Jul. 09 | Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing | MT |
Jul. 08 | Emergent, J&J settle COVID vaccine supply deal dispute | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+343.75% | 558M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Transcript : Emergent BioSolutions Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 through Jan-11-2018